325 related articles for article (PubMed ID: 28993096)
1. Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells.
Leti F; Legendre C; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK
Transl Res; 2017 Dec; 190():25-39.e21. PubMed ID: 28993096
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
[TBL] [Abstract][Full Text] [Related]
3. Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis.
Li XQ; Ren ZX; Li K; Huang JJ; Huang ZT; Zhou TR; Cao HY; Zhang FX; Tan B
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495545
[TBL] [Abstract][Full Text] [Related]
4. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.
Chu X; Jin Q; Chen H; Wood GC; Petrick A; Strodel W; Gabrielsen J; Benotti P; Mirshahi T; Carey DJ; Still CD; DiStefano JK; Gerhard GS
J Transl Med; 2018 Apr; 16(1):108. PubMed ID: 29690903
[TBL] [Abstract][Full Text] [Related]
5. Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis.
Gerhard GS; Davis B; Wu X; Hanson A; Wilhelmsen D; Piras IS; Still CD; Chu X; Petrick AT; DiStefano JK
Biochem Biophys Rep; 2020 Jul; 22():100753. PubMed ID: 32258441
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of murine long noncoding single-cell transcriptome in nonalcoholic steatohepatitis and liver fibrosis.
Karri K; Waxman DJ
RNA; 2023 Jul; 29(7):977-1006. PubMed ID: 37015806
[TBL] [Abstract][Full Text] [Related]
7. AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p.
Gerhard GS; Hanson A; Wilhelmsen D; Piras IS; Still CD; Chu X; Petrick AT; DiStefano JK
PLoS One; 2019; 14(7):e0219764. PubMed ID: 31299062
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis.
Atanasovska B; Rensen SS; Marsman G; Shiri-Sverdlov R; Withoff S; Kuipers F; Wijmenga C; van de Sluis B; Fu J
Cells; 2021 Jul; 10(8):. PubMed ID: 34440652
[TBL] [Abstract][Full Text] [Related]
9. MALAT1 promotes liver fibrosis by sponging miR‑181a and activating TLR4‑NF‑κB signaling.
Wang Y; Mou Q; Zhu Z; Zhao L; Zhu L
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34651657
[TBL] [Abstract][Full Text] [Related]
10. The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD.
Li JZ; Ye LH; Wang DH; Zhang HC; Li TY; Liu ZQ; Dai EH; Li MR
Virus Res; 2021 Jun; 298():198405. PubMed ID: 33775752
[TBL] [Abstract][Full Text] [Related]
11. Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p.
Hanson A; Piras IS; Wilhelmsen D; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK
Cytokine; 2019 Nov; 123():154789. PubMed ID: 31352173
[TBL] [Abstract][Full Text] [Related]
12. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
[TBL] [Abstract][Full Text] [Related]
13. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
[TBL] [Abstract][Full Text] [Related]
14. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
15. ATP Citrate Lyase and LncRNA NONMMUT010685 Play Crucial Role in Nonalcoholic Fatty Liver Disease Based on Analysis of Microarray Data.
Ma TT; Huang C; Ni Y; Yang Y; Li J
Cell Physiol Biochem; 2018; 51(2):871-885. PubMed ID: 30466110
[TBL] [Abstract][Full Text] [Related]
16. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease.
Wiering L; Subramanian P; Hammerich L
Cell Mol Gastroenterol Hepatol; 2023; 15(6):1277-1292. PubMed ID: 36828280
[TBL] [Abstract][Full Text] [Related]
18. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
Kimura T; Singh S; Tanaka N; Umemura T
Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
[TBL] [Abstract][Full Text] [Related]
19. Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage.
Sookoian S; Flichman D; Garaycoechea ME; San Martino J; Castaño GO; Pirola CJ
Hepatol Commun; 2018 Jun; 2(6):654-665. PubMed ID: 29881817
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease.
Romualdo GR; Da Silva TC; de Albuquerque Landi MF; Morais JÁ; Barbisan LF; Vinken M; Oliveira CP; Cogliati B
Environ Toxicol; 2021 Feb; 36(2):168-176. PubMed ID: 32918399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
